• Alan A. Aderem, PhD
  Professor and Director, Institute for Systems Biology 
   

• Michel De Wilde, PhD
  Executive Vice President, Research and Development, Sanofi Pasteur

• Peter C. Doherty, PhD
  Michael F. Tamer Chair, Department of Immunology, St. Jude Children's Research Hospital; Laureate Professor, Department of Microbiology and Immunology, The University of Melbourne
  
  

• José Esparza, MD, PhD
  Senior Advisor, HIV Vaccines, Bill & Melinda Gates Foundation

• Harry B. Greenberg, MD
  Senior Associate Dean of Research, Joseph D. Grant Professor of Medicine and Microbiology and Immunology, School of Medicine, Stanford University

• Ian Gust, MD (Chair)
  Professorial Fellow, Department of Microbiology and Immunology, University of Melbourne;
  Former Director, Research and Development, CSL Ltd.

• Nancy Logan Haigwood, PhD
  Director, Oregon National Primate Research Center; Professor of Pathology, School of Public Health and Community Medicine; Professor of Microbiology, School of Medicine, Seattle Biomedical Research Institute; Member, Viral Vaccines Program, Seattle Biomedical Research Institute;

• Salim Abdool Karim, MBChB, PhD
  Professor, Centre for the AIDS Programme of Research in South Africa, Nelson R. Mandela School of Medicine,

  University of KwaZulu-Natal

• Marie-Paule Kieny, PhD (Ex-officio)
  Director, Initiative for Vaccine Research, World Health Organization

• Reinhard Kurth, MD
  President Emeritus, Robert Koch Institute

• Thomas P. Monath, MD
  Partner, Kleiner Perkins Caufield and Byers,

  Pandemic and Defense Fund

• Marian R. Neutra, PhD
  Professor of Pediatrics, Harvard Medical School and Children's Hospital of Boston
  

• Jerald C. Sadoff, MD
  President and Chief Executive Officer, Aeras Global Tuberculosis Vaccine Foundation

• Robin A. Weiss, PhD
  Professor of Viral Oncology, Division of Infection and Immunity, University College London

Policy Advisory Committee:

• David Kihumuro Apuuli, MD
  Director-General, Uganda AIDS Commission

• Emma Back, MA
  Independent Consultant
  
• Ciro de Quadros, MD, MPH
  Director, International Programs, Albert B. Sabin Vaccine Institute; Former Director, Vaccines and Immunization, Pan American Health Organization

• Christopher J. Elias, MD, MPH
  President, PATH

• José Esparza, MD, PhD
  Senior Advisor, HIV Vaccines, Bill and Melinda Gates Foundation Global Health Program

• Michel Gréco, MS, MBA
  Former President, Chief Operating Officer and Deputy Chief Executive Officer, Aventis Pasteur; Former President and Chief Operating Officer, Pasteur Mérieux MSD

• David L. Heyman, MD (Observer)
  Chairman of the Board, UK Health Protection Agency
• Purnima Mane, PhD, MA, MPhil
  Deputy Executive Director, United Nations Population Fund


• Jeffrey Sturchio, PhD

  President & CEO, Global Health Council

• Mark A. Wainberg, PhD
  Professor and Director, McGill University AIDS Centre

• Mitchell Warren (Observer)
  Executive Director, AIDS Vaccine Advocacy Coalition

• Alan Whiteside, MA, D Econ
  Director, Health Economics and HIV/AIDS Research Division, University of KwaZulu-Natal